Disease table

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Disease phenotype
OMIM
Gene symbol (chromosome)
protein
Paramyotonia congenita of Von Eulenburg (7.3, 7.5, 7.4, 7.6, 11.20)
SCN4A (17q23-q25.3)
sodium channel, voltage-gated, type IV, alpha

patient with HCM and isolated respiratory complex I deficiency (10.24)
NDUFAF1 (15q15.1)
NADH-ubiquinone oxidoreductase 1 alpha subcomplex

Pelizaeus-Merzbacher disease (15.44)
PLP1 (Xq22)
proteolipid protein 1

Perineal hypospadias (12.32)
AR (Xq11.2-q12)
androgen receptor

Periodic paralysis, potassium-sensitive cardiodysrhythmic Andersen-Tawil syndrom (7.14, 10.93, 10.98)
KCNJ2 (17q23)
potassium inwardly-rectifying channel J2

Phosphoglycerate kinase 1 pseudogene1 included (9.11)
PGK1 (Xq13)
phosphoglycerate kinase 1

Phosphoglycerate kinase 1 pseudogene2 included (9.11)
PGK1 (Xq13)
phosphoglycerate kinase 1

Pontocerebellar hypoplasia type 1 (12.36)
VRK1 (14q32)
vaccinia related kinase 1

posphoglycerate kinase deficiency (9.11)
PGK1 (Xq13)
phosphoglycerate kinase 1

Potassium-aggravated myotonia (7.3, 7.5, 7.4, 7.6, 11.20)
SCN4A (17q23-q25.3)
sodium channel, voltage-gated, type IV, alpha

Primary lateral sclerosis, juvenile (12.23, 15.42)
ALS2 (2q33.2)
alsin

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal (16.23, 16.20)
RRM2B (8q23.1)
ribonucleotide reductase M2 B (TP53 inducible)

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal (16.17)
SLC25A4 (4q35)
mitochondrial carrier; adenine nucleotide translocator

Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal (16.16, 13.51)
POLG (15q25)
polymerase (DNA directed), gamma

Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal (13.39, 16.18)
PEO1 (10q23.3-q24.3)
twinkle/twinky (mt DNA helicase)

progressive external ophthalmoplegia, autosomal dominant, 4 (16.19)
POLG2 (17q24.1)
mitochondrial DNA polymerase, accessory subunit

Progressive familial heart block, type I (10.89, 7.7, 10.31, 10.111, 10.116)
SCN5A (3p21)
voltage-gated sodium channel type V alpha

Prostate cancer (12.32)
AR (Xq11.2-q12)
androgen receptor

Proximal myotonic myopathy (6.2)
ZNF9 (3q21)
zinc finger protein 9